Elanco Animal Net Worth

Elanco Animal Net Worth Breakdown

  ELAN
The net worth of Elanco Animal Health is the difference between its total assets and liabilities. Elanco Animal's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Elanco Animal's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Elanco Animal's net worth can be used as a measure of its financial health and stability which can help investors to decide if Elanco Animal is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Elanco Animal Health stock.

Elanco Animal Net Worth Analysis

Elanco Animal's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Elanco Animal's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Elanco Animal's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Elanco Animal's net worth analysis. One common approach is to calculate Elanco Animal's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Elanco Animal's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Elanco Animal's net worth. This approach calculates the present value of Elanco Animal's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Elanco Animal's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Elanco Animal's net worth. This involves comparing Elanco Animal's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Elanco Animal's net worth relative to its peers.
To determine if Elanco Animal is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Elanco Animal's net worth research are outlined below:
Elanco Animal Health generated a negative expected return over the last 90 days
Elanco Animal Health is unlikely to experience financial distress in the next 2 years
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Elanco Animal Health Among the Most Undervalued Biotech Stocks to Invest In

Elanco Animal Quarterly Good Will

4.41 Billion

Elanco Animal uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Elanco Animal Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Elanco Animal's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Elanco Animal Target Price Consensus

Elanco target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Elanco Animal's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   16  Buy
Most Elanco analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Elanco stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Elanco Animal Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Elanco Animal Target Price Projection

Elanco Animal's current and average target prices are 10.53 and 17.33, respectively. The current price of Elanco Animal is the price at which Elanco Animal Health is currently trading. On the other hand, Elanco Animal's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Elanco Animal Market Quote on 22nd of March 2025

Low Price10.32Odds
High Price10.68Odds

10.53

Target Price

Analyst Consensus On Elanco Animal Target Price

Low Estimate15.77Odds
High Estimate19.24Odds

17.3333

Historical Lowest Forecast  15.77 Target Price  17.33 Highest Forecast  19.24
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Elanco Animal Health and the information provided on this page.

Know Elanco Animal's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Elanco Animal is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elanco Animal Health backward and forwards among themselves. Elanco Animal's institutional investor refers to the entity that pools money to purchase Elanco Animal's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
State Street Corp2024-12-31
10.4 M
Geode Capital Management, Llc2024-12-31
8.2 M
Jpmorgan Chase & Co2024-12-31
7.5 M
Manufacturers Life Insurance Co2024-12-31
6.9 M
Brandes Investment Partners & Co2024-12-31
5.7 M
Charles Schwab Investment Management Inc2024-12-31
4.7 M
Prudential Financial Inc2024-12-31
4.2 M
Ubs Group Ag2024-12-31
4.2 M
Canada Pension Plan Investment Board2024-12-31
M
Dodge & Cox2024-12-31
83.2 M
Primecap Management Company2024-12-31
51.2 M
Note, although Elanco Animal's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Elanco Animal's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.23 B.

Market Cap

0.0

Project Elanco Animal's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets 0.07  0.08 
Return On Capital Employed 0.02  0.03 
Return On Assets 0.03  0.03 
Return On Equity 0.06  0.06 
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01.
When accessing Elanco Animal's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Elanco Animal's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Elanco Animal's profitability and make more informed investment decisions.

Evaluate Elanco Animal's management efficiency

Elanco Animal Health has return on total asset (ROA) of 0.0119 % which means that it generated a profit of $0.0119 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0549 %, meaning that it created $0.0549 on every $100 dollars invested by stockholders. Elanco Animal's management efficiency ratios could be used to measure how well Elanco Animal manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of March 2025, Return On Tangible Assets is likely to grow to 0.08. Also, Return On Capital Employed is likely to grow to 0.03. At this time, Elanco Animal's Total Assets are very stable compared to the past year. As of the 22nd of March 2025, Non Current Assets Total is likely to grow to about 10.5 B, though Net Tangible Assets are likely to grow to (3 B).
Last ReportedProjected for Next Year
Book Value Per Share 12.34  18.06 
Tangible Book Value Per Share(4.05)(4.25)
Enterprise Value Over EBITDA 7.10  7.46 
Price Book Value Ratio 0.98  1.68 
Enterprise Value Multiple 7.10  7.46 
Price Fair Value 0.98  1.68 
Evaluating the management effectiveness of Elanco Animal allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Elanco Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue
2.0747
Revenue
4.4 B
Quarterly Revenue Growth
(0.01)
Revenue Per Share
8.986
Return On Equity
0.0549
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elanco Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elanco Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elanco Animal insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Elanco Animal Corporate Filings

8K
17th of March 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
11th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
7th of March 2025
Other Reports
ViewVerify
12th of February 2025
Other Reports
ViewVerify
Elanco Animal time-series forecasting models is one of many Elanco Animal's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Elanco Animal's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Elanco Animal Earnings Estimation Breakdown

The calculation of Elanco Animal's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Elanco Animal is estimated to be 0.3118 with the future projection ranging from a low of 0.29 to a high of 0.3204. Please be aware that this consensus of annual earnings estimates for Elanco Animal Health is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.14
0.29
Lowest
Expected EPS
0.3118
0.32
Highest

Elanco Animal Earnings Projection Consensus

Suppose the current estimates of Elanco Animal's value are higher than the current market price of the Elanco Animal stock. In this case, investors may conclude that Elanco Animal is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Elanco Animal's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
1678.63%
0.14
0.3118
0.68

Elanco Animal Earnings History

Earnings estimate consensus by Elanco Animal Health analysts from Wall Street is used by the market to judge Elanco Animal's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Elanco Animal's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Elanco Animal Quarterly Gross Profit

389 Million

At this time, Elanco Animal's Earnings Yield is very stable compared to the past year. As of the 22nd of March 2025, Price Earnings Ratio is likely to grow to 18.58, though Retained Earnings are likely to grow to (1.9 B). As of the 22nd of March 2025, Common Stock Shares Outstanding is likely to drop to about 457.5 M. In addition to that, Net Loss is likely to drop to about (73.7 M).
Hype
Prediction
LowEstimatedHigh
8.3410.4612.58
Details
Intrinsic
Valuation
LowRealHigh
10.2012.3214.44
Details
Naive
Forecast
LowNextHigh
8.4910.6112.72
Details
16 Analysts
Consensus
LowTargetHigh
15.7717.3319.24
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Elanco Animal. Your research has to be compared to or analyzed against Elanco Animal's peers to derive any actionable benefits. When done correctly, Elanco Animal's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Elanco Animal Health. Note that many institutional investors and large investment bankers can move markets due to the volume of Elanco assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Elanco Animal. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Elanco Animal's stock price in the short term.

Elanco Animal Earnings per Share Projection vs Actual

Actual Earning per Share of Elanco Animal refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Elanco Animal Health predict the company's earnings will be in the future. The higher the earnings per share of Elanco Animal, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Elanco Animal Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Elanco Animal, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Elanco Animal should always be considered in relation to other companies to make a more educated investment decision.

Elanco Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Elanco Animal's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-24
2024-12-310.14860.14-0.0086
2024-11-07
2024-09-300.120.130.01
2024-08-08
2024-06-300.240.30.0625 
2024-05-08
2024-03-310.260.340.0830 
2024-02-26
2023-12-310.110.08-0.0327 
2023-11-07
2023-09-300.120.180.0650 
2023-08-07
2023-06-300.050.180.13260 
2023-05-09
2023-03-310.290.450.1655 
2023-02-21
2022-12-310.130.190.0646 
2022-11-08
2022-09-300.160.20.0425 
2022-08-08
2022-06-300.250.360.1144 
2022-05-09
2022-03-310.350.360.01
2022-02-24
2021-12-310.170.210.0423 
2021-11-05
2021-09-300.170.190.0211 
2021-08-09
2021-06-300.260.280.02
2021-05-07
2021-03-310.230.370.1460 
2021-02-24
2020-12-310.090.120.0333 
2020-11-06
2020-09-300.120.130.01
2020-07-30
2020-06-300.060.090.0350 
2020-05-07
2020-03-310.240.13-0.1145 
2020-02-19
2019-12-310.230.230.0
2019-11-06
2019-09-300.260.30.0415 
2019-08-13
2019-06-300.260.280.02
2019-05-09
2019-03-310.230.250.02
2019-02-06
2018-12-310.280.290.01
2018-11-06
2018-09-300.250.290.0416 
2018-09-21
2018-06-300-0.97-0.97

Elanco Animal Corporate Directors

Joshua SmileyIndependent DirectorProfile
Carl McMillianIndependent DirectorProfile
Denise ScotsKnightIndependent DirectorProfile
Kirk McDonaldIndependent DirectorProfile
When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.71)
Earnings Share
0.68
Revenue Per Share
8.986
Quarterly Revenue Growth
(0.01)
Return On Assets
0.0119
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.